Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma

Cancer

Volumn 97, Issue 1, 2003, Pages 79-89

  Isaka, Keiichi ^a   Nishi, Hirotaka ^a   Nakai, Hiromi ^a   Nakada, Toshihide ^a   Feng Li, Yin ^a   Ebihara, Yoshiro ^a   Takayama, Masaomi ^a   Nozawa, Shiro ^b   Mizusawa, Yuki ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; Endometrium; MMP 26 (matrilysin 2, endometase); MMP 7

Indexed keywords

MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; MESSENGER RNA; RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENZYME LOCALIZATION; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; STROMA CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA PRIMERS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, SECRETED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 0037217258     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11030     Document Type: Article

References (24)

1. Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
2. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QX. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000;275:20540-20544.
3. Seiki M. Membrane-type matrix metalloproteinases. Apmis. 1999;107:137-143.
4. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993;9:541-573.
5. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med. 1996;2:461-462.
6. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-1149.
7. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997;89:1260-1270.
8. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999;98:137-146.
9. Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G, Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 1999;274: 4570-4576.
10. de Coignac AB, Elson G, Delneste Y, et al. Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem. 2000; 267:3323-3329.
11. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI, Strongin AY. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J. 2001;356(Pt 3):705-718.
12. Uria JA, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res. 2000;60:4745-4751.
13. Yudate T, Isaka K, Okabe K, Takayama M. Establishment and characterization of the new cell line (EI) from a human endometrial adenocarcinoma. Hum Cell. 1995;8: 43-48.
14. Nozawa S, Sakayori M, Ohta K, et al. A monoclonal antibody (MSN-1) against a newly established uterine endometrial cancer cell line (SNG-II) and its application to immunohistochemistry and flow cytometry. Am J Obstet Gynecol. 1989; 161:1079-1086.
15. Richardson GS, Dickersin GR, Atkins L, et al. KLE: A cell line with defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol. 1984;17:213-230.
16. Satyaswaroop PG, Frost A, Gurpide E. Metabolism and effects of progesterone in the human endometrial adenocarcinoma cell line HEC-1. Steroids. 1980;35:21-37.
17. Satyaswaroop PG, Bressler RS, de la Pena MM, Gurpide E. Isolation and culture of human endometrial glands. J Clin Endocrinol Metab. 1979;48:639-641.
18. Ueno H, Yamashita K, Azumano I, Inoue M, Okada Y. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer. 1999;84:470-477.
19. Sibony M, Commo F, Callard P, Gasc JM. Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest. 1995;73:586-591.
20. Li H, Bauzon DE, Xu X, Tschesche H, Cao J, Sang QA. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinogen. 1998;22:84-94.
21. Hickey M, Fraser IS. The structure of endometrial microvessels. Hum Reprod. 2000;15 (Suppl 3):57-66.
22. Marchenko GN, Marchenko ND, Leng J, Strongin AY. Promoter characterization of the novel human matrix metalloproteinase-26 gene: Regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J. 2002;363(Pt 2):253-262.
23. Suprun HZ, Taendler-Stolero R, Schwartz J, Ettinger M. Experience with Endopap endometrial sampling in the cytodiagnosis of endometrial carcinoma and its precursor lesions. I. A correlative cytologic-histologic-hysteroscopic diagnostic pilot study. Acta Cytol. 1994;38:319-323.
24. Foulks MJ. The Papanicolaou smear: its impact on the promotion of women's health. J Obstet Gynecol Neonatal Nurs. 1998;27:367-373.